Skip to main content
Erschienen in: Digestive Diseases and Sciences 10/2017

30.08.2017 | Original Article

Tubercular Intestinal Strictures Show a Poor Response to Anti-Tuberculous Therapy

verfasst von: Piyush Aggarwal, Saurabh Kedia, Raju Sharma, Sawan Bopanna, Kumble Seetharama Madhusudhan, Dawesh P. Yadav, Sandeep Goyal, Saransh Jain, Venigalla Pratap Mouli, Prasenjit Das, Siddhartha Dattagupta, Govind Makharia, Vineet Ahuja

Erschienen in: Digestive Diseases and Sciences | Ausgabe 10/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

The literature on resolution of intestinal strictures in patients with intestinal tuberculosis (ITB) after anti-tuberculous therapy (ATT) is sparse and ambivalent. We aimed to assess the frequency of stricture resolution after ATT and its predictors.

Methods

This ambispective cohort study included consecutive ITB patients with strictures who received ATT for ≥6 months and were on regular follow-up between January 2004 and December 2015. Resolution of stricture was assessed at the end of ATT by endoscopy/radiology.

Results

Of 286 patients, 128 had strictures, and 106 were finally included (63 males, median age 35 years). The stricture location was distal ileum/ileocecal in 52 (49.1%), colon in 37 (34.9%), ileocolonic in 4 (3.8%), proximal small bowel in 10 (9.4%), and gastroduodenal in 4 (3.8%) patients. Although all patients demonstrated mucosal healing (indicating resolution of active infection), stricture resolution occurred only in 25/106 (23.6%) patients. Symptoms pertaining to stricture (pain abdomen/recurrent SAIO) were present in 104/106 (98%) patients, and after a median of 6 (6–9) months of ATT, these symptoms resolved only in half, 88% (22/25) in patients with stricture resolution and 38% (30/79) in patients with persistent strictures. Colonic strictures had the least resolution (5.4%) followed by proximal small intestinal (20%) and distal ileal/ileocecal (36.5%). Although not statistically significant, stricture resolution was less frequent in patients with multiple strictures, longer strictures (>3 cm), and strictures in which scope was not negotiable prior to ATT.

Conclusion

Only one-fourth of ITB patients with strictures show resolution of stricture following ATT. The resolution of strictures is dependent on disease location, and majority of them exhibit symptoms pertaining to stricture even after ATT.
Literatur
1.
Zurück zum Zitat Kedia S, Sharma R, Nagi B, et al. Computerized tomography-based predictive model for differentiation of Crohn’s disease from intestinal tuberculosis. Indian J Gastroenterol. 2015;34:135–143.CrossRefPubMed Kedia S, Sharma R, Nagi B, et al. Computerized tomography-based predictive model for differentiation of Crohn’s disease from intestinal tuberculosis. Indian J Gastroenterol. 2015;34:135–143.CrossRefPubMed
2.
Zurück zum Zitat Smith A. Streptomycin in treatment of tuberculosis: Council on Pharmacy and Chemistry. JAMA. 1948;138:548–593. Smith A. Streptomycin in treatment of tuberculosis: Council on Pharmacy and Chemistry. JAMA. 1948;138:548–593.
3.
Zurück zum Zitat Sweany HC, Lichtenstein MR, et al. Streptomycin treatment of tuberculous enterocolitis; results in 30 cases. Am Rev Tuberc. 1949;60:576–588. PubMed PMID: 15392762.PubMed Sweany HC, Lichtenstein MR, et al. Streptomycin treatment of tuberculous enterocolitis; results in 30 cases. Am Rev Tuberc. 1949;60:576–588. PubMed PMID: 15392762.PubMed
4.
Zurück zum Zitat Mason EF, Kridelbaugh WE. Streptomycin in the treatment of tuberculous enteritis; a report of 33 cases. Am J Med Sci. 1949;217:28–46.CrossRefPubMed Mason EF, Kridelbaugh WE. Streptomycin in the treatment of tuberculous enteritis; a report of 33 cases. Am J Med Sci. 1949;217:28–46.CrossRefPubMed
5.
Zurück zum Zitat Pimparkar BD. Abdominal tuberculosis. J Assoc Physicians India. 1977;25:801–811.PubMed Pimparkar BD. Abdominal tuberculosis. J Assoc Physicians India. 1977;25:801–811.PubMed
6.
Zurück zum Zitat Jordan GL Jr, De Bakey ME. Complications of tuberculous enteritis occurring during antimicrobial therapy. AMA Arch Surg. 1954;69:688–693.CrossRefPubMed Jordan GL Jr, De Bakey ME. Complications of tuberculous enteritis occurring during antimicrobial therapy. AMA Arch Surg. 1954;69:688–693.CrossRefPubMed
8.
Zurück zum Zitat Mukewar S, Mukewar S, Ravi R, Prasad A, Dua KS. Colon tuberculosis: endoscopic features and prospective endoscopic follow-up after anti-tuberculosis treatment. Clin Transl Gastroenterol. 2012;3:e24.CrossRefPubMedPubMedCentral Mukewar S, Mukewar S, Ravi R, Prasad A, Dua KS. Colon tuberculosis: endoscopic features and prospective endoscopic follow-up after anti-tuberculosis treatment. Clin Transl Gastroenterol. 2012;3:e24.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Hara AK, Leighton JA, Heigh RI, et al. Crohn disease of the small bowel: preliminary comparison among CT enterography, capsule endoscopy, small-bowel follow-through, and ileoscopy. Radiology. 2006;238:128–134.CrossRefPubMed Hara AK, Leighton JA, Heigh RI, et al. Crohn disease of the small bowel: preliminary comparison among CT enterography, capsule endoscopy, small-bowel follow-through, and ileoscopy. Radiology. 2006;238:128–134.CrossRefPubMed
10.
Zurück zum Zitat Lee SS, Kim AY, Yang SK, et al. Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques. Radiology. 2009;251:751–761.CrossRefPubMed Lee SS, Kim AY, Yang SK, et al. Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques. Radiology. 2009;251:751–761.CrossRefPubMed
11.
Zurück zum Zitat Krishna S, Kalra N, Singh P, et al. Small-bowel tuberculosis: a comparative study of MR enterography and small-bowel follow-through. AJR Am J Roentgenol. 2016;207:571–577.CrossRefPubMed Krishna S, Kalra N, Singh P, et al. Small-bowel tuberculosis: a comparative study of MR enterography and small-bowel follow-through. AJR Am J Roentgenol. 2016;207:571–577.CrossRefPubMed
13.
Zurück zum Zitat Paustian F. Tuberculosis of the intestine. In: Bockus HL, ed. Bockus gastroenterology. 5th ed. Philadelphia: Saunders; 1995:3304. Paustian F. Tuberculosis of the intestine. In: Bockus HL, ed. Bockus gastroenterology. 5th ed. Philadelphia: Saunders; 1995:3304.
14.
Zurück zum Zitat Pratap Mouli V, Munot K, Ananthakrishnan A, et al. Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn’s disease. Aliment Pharmacol Ther. 2017;45:27–36.CrossRefPubMed Pratap Mouli V, Munot K, Ananthakrishnan A, et al. Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn’s disease. Aliment Pharmacol Ther. 2017;45:27–36.CrossRefPubMed
15.
Zurück zum Zitat Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63:e147–e195.CrossRefPubMed Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63:e147–e195.CrossRefPubMed
16.
Zurück zum Zitat Rimola J, Planell N, Rodríguez S, et al. Characterization of inflammation and fibrosis in Crohn’s disease lesions by magnetic resonance imaging. Am J Gastroenterol. 2015;110:432–440.CrossRefPubMed Rimola J, Planell N, Rodríguez S, et al. Characterization of inflammation and fibrosis in Crohn’s disease lesions by magnetic resonance imaging. Am J Gastroenterol. 2015;110:432–440.CrossRefPubMed
17.
Zurück zum Zitat Booya F, Fletcher JG, Huprich JE, et al. Active Crohn disease: CT findings and interobserver agreement for enteric phase CT enterography. Radiology. 2006;241:787–795.CrossRefPubMed Booya F, Fletcher JG, Huprich JE, et al. Active Crohn disease: CT findings and interobserver agreement for enteric phase CT enterography. Radiology. 2006;241:787–795.CrossRefPubMed
18.
Zurück zum Zitat Bettenworth D, Rieder F. Pathogenesis of intestinal fibrosis in inflammatory bowel disease and perspectives for therapeutic implication. Dig Dis. 2017;35:25–31.CrossRefPubMed Bettenworth D, Rieder F. Pathogenesis of intestinal fibrosis in inflammatory bowel disease and perspectives for therapeutic implication. Dig Dis. 2017;35:25–31.CrossRefPubMed
19.
Zurück zum Zitat Makharia GK, Ghoshal UC, Ramakrishna BS, et al. Intermittent directly observed therapy for abdominal tuberculosis: a multicenter randomized controlled trial comparing 6 months versus 9 months of therapy. Clin Infect Dis. 2015;61:750–757.CrossRefPubMed Makharia GK, Ghoshal UC, Ramakrishna BS, et al. Intermittent directly observed therapy for abdominal tuberculosis: a multicenter randomized controlled trial comparing 6 months versus 9 months of therapy. Clin Infect Dis. 2015;61:750–757.CrossRefPubMed
20.
Zurück zum Zitat Misra SP, Misra V, Dwivedi M, Arora JS, Kunwar BK. Tuberculous colonic strictures: impact of dilation on diagnosis. Endoscopy. 2004;36:1099–1103.CrossRefPubMed Misra SP, Misra V, Dwivedi M, Arora JS, Kunwar BK. Tuberculous colonic strictures: impact of dilation on diagnosis. Endoscopy. 2004;36:1099–1103.CrossRefPubMed
Metadaten
Titel
Tubercular Intestinal Strictures Show a Poor Response to Anti-Tuberculous Therapy
verfasst von
Piyush Aggarwal
Saurabh Kedia
Raju Sharma
Sawan Bopanna
Kumble Seetharama Madhusudhan
Dawesh P. Yadav
Sandeep Goyal
Saransh Jain
Venigalla Pratap Mouli
Prasenjit Das
Siddhartha Dattagupta
Govind Makharia
Vineet Ahuja
Publikationsdatum
30.08.2017
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 10/2017
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-017-4727-3

Weitere Artikel der Ausgabe 10/2017

Digestive Diseases and Sciences 10/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.